申请人:Xuanzhu Pharma Co., Ltd.
公开号:EP2781520A1
公开(公告)日:2014-09-24
The present application relates to a compound as represented by general formula (I), a pharmaceutically acceptable salt, ester, solvate or stereoisomer thereof, preparation method of the compounds, a pharmaceutical composition containing the compounds, uses thereof in the preparation of drugs for treating and/or preventing proliferative diseases, and a method using the compounds to treat and/or prevent proliferative diseases. R1, R2, R3, R4, R5, R6, X, A and B in the formula are as defined in the specification.
本申请涉及通式(I)代表的化合物、其药学上可接受的盐、酯、溶剂或立体异构体、化合物的制备方法、含有化合物的药物组合物、其在制备治疗和/或预防增殖性疾病药物中的用途,以及使用化合物治疗和/或预防增殖性疾病的方法。式中的 R1、R2、R3、R4、R5、R6、X、A 和 B 如说明书中所定义。